Quantbot Technologies’s Syndax Pharmaceuticals SNDX Stock Holding History

Quantbot Technologies’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.9K	Buy	2,350 +1,161	+98%	+$25.2K	﹤0.01%	1406
2025 Q4	$25K	Sell	1,189 -2,282	-66%	-$39.8K	﹤0.01%	1555
2025 Q3	$53.4K	Buy	+3,471	New	+$45.4K	﹤0.01%	1515
2025 Q1	–	Sell	-1,086	Closed	-$14.4K	–	1846
2024 Q4	$14.4K	Sell	1,086 -1,456	-57%	-$24.9K	﹤0.01%	1368
2024 Q3	$48.9K	Buy	+2,542	New	+$52.5K	﹤0.01%	1292
2023 Q4	–	Sell	-9,000	Closed	-$131K	–	1959
2023 Q3	$131K	Buy	+9,000	New	+$170K	0.01%	1028
2022 Q2	–	Sell	-4,900	Closed	-$85K	–	2100
2022 Q1	$85K	Sell	4,900 -446	-8%	-$7.51K	0.01%	1082
2021 Q4	$117K	Buy	+5,346	New	+$98.8K	0.01%	838
2021 Q2	–	Sell	-700	Closed	-$15K	–	1836
2021 Q1	$15K	Hold	700	–	–	﹤0.01%	1209
2020 Q4	$15K	Sell	700 -200	-22%	-$4.15K	﹤0.01%	1054
2020 Q3	$13K	Buy	+900	New	+$13.7K	﹤0.01%	1070

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Quantbot Technologies's SNDX Position: Q1 2026 in Review

Quantbot Technologies increased its Syndax Pharmaceuticals (SNDX) stake by 98% in Q1 2026, buying an estimated $25.2K and bringing the position to 2,350 shares worth $54.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1406.

Quantbot Technologies first reported a position in SNDX in Q3 2020 and has held it in 11 quarters since. The position peaked at $131K in Q3 2023. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Quantbot Technologies held 2,350 shares of Syndax Pharmaceuticals worth $54.9K as of Q1 2026.
Quantbot Technologies bought 1,161 Syndax Pharmaceuticals shares in Q1 2026, an estimated $25.2K.
Syndax Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1406 holding.
Quantbot Technologies first reported a position in Syndax Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
Quantbot Technologies's Syndax Pharmaceuticals position peaked at $131K in Q3 2023.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.